These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 6120176)
1. Summary of symposium on cerebral blood flow: effect of nerves and neurotransmitters. Cardiovascular Center, University of Iowa, Iowa City, Iowa, June 16--18, 1981. Heistad DD J Cereb Blood Flow Metab; 1981; 1(4):447-50. PubMed ID: 6120176 [No Abstract] [Full Text] [Related]
2. Neural effects on cerebral vessels: alteration of pressure-flow relationship. Heistad DD; Busija DW; Marcus ML Fed Proc; 1981 Jun; 40(8):2317-21. PubMed ID: 7238912 [TBL] [Abstract][Full Text] [Related]
3. Factors involved in the physiological regulation of the cerebral circulation. Busija DW; Heistad DD Rev Physiol Biochem Pharmacol; 1984; 101():161-211. PubMed ID: 6441228 [No Abstract] [Full Text] [Related]
4. [Regulation of cerebral circulation by neurotransmitters]. Jia WG Sheng Li Ke Xue Jin Zhan; 1984 Jul; 15(3):214-7. PubMed ID: 6151253 [No Abstract] [Full Text] [Related]
5. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system. Wu D; Pardridge WM J Pharmacol Exp Ther; 1996 Oct; 279(1):77-83. PubMed ID: 8858978 [TBL] [Abstract][Full Text] [Related]
6. [Cholecystokinin and vasoactive intestinal polypeptide (VIP) in the central nervous system]. Krowicki Z; Sadowska-Krowicka H Postepy Hig Med Dosw; 1983; 37(1):75-85. PubMed ID: 6138762 [No Abstract] [Full Text] [Related]
7. Protection of the blood-brain barrier during acute and chronic hypertension. Heistad DD Fed Proc; 1984 Feb; 43(2):205-9. PubMed ID: 6692940 [TBL] [Abstract][Full Text] [Related]
8. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice. Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894 [TBL] [Abstract][Full Text] [Related]
10. Role of perivascular sympathetic nerves in autoregulation of cerebral blood flow and in blood-brain barrier functions. Edvinsson L; Hardebo JE; Owman C Acta Neurol Scand Suppl; 1977; 64():50-1. PubMed ID: 268889 [No Abstract] [Full Text] [Related]
11. Neurogenic control of the cerebral circulation. Branston NM Cerebrovasc Brain Metab Rev; 1995; 7(4):338-49. PubMed ID: 8703674 [No Abstract] [Full Text] [Related]
12. Regulation of glycogenolysis by neurotransmitters in the central nervous system. Magistretti PJ Diabete Metab; 1988; 14(3):237-46. PubMed ID: 2900788 [TBL] [Abstract][Full Text] [Related]
16. [Link between cerebral blood flow and brain metabolism: validity and limits]. Pinard E Agressologie; 1991; 32(6-7):359-65. PubMed ID: 1688221 [TBL] [Abstract][Full Text] [Related]
17. Cholinergic and vasoactive intestinal polypeptidergic innervation of the cerebral arteries. Dauphin F; MacKenzie ET Pharmacol Ther; 1995; 67(3):385-417. PubMed ID: 8577823 [TBL] [Abstract][Full Text] [Related]
18. VIP: Possible functions as a neural peptide. Said SI; Giachetti A; Nicosia S Adv Biochem Psychopharmacol; 1980; 22():75-82. PubMed ID: 6104904 [No Abstract] [Full Text] [Related]
19. Chemical communication in the CNS: neurotransmitters and their function. Bloom FE Prog Brain Res; 1983; 58():3-9. PubMed ID: 6138811 [No Abstract] [Full Text] [Related]
20. Cerebral circulatory and metabolic effects of perivascular neurotransmitters. MacKenzie ET; Scatton B CRC Crit Rev Clin Neurobiol; 1987; 2(4):357-419. PubMed ID: 3297495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]